These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 24816170)

  • 21. Azole resistance in Aspergillus fumigatus: a new challenge in the management of invasive aspergillosis?
    Snelders E; Melchers WJ; Verweij PE
    Future Microbiol; 2011 Mar; 6(3):335-47. PubMed ID: 21449843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Invasive pulmonary aspergillosis due to a multi-azole resistant Aspergillus fumigatus.
    Jeurissen A; Cooreman S; Van Kerckhoven W; Van Leemput J; Vanhove P; Lagrou K; Heytens L
    Acta Clin Belg; 2012; 67(1):46-8. PubMed ID: 22480040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay® in 201 patients with haematological disease suspected for invasive aspergillosis.
    Chong GM; van der Beek MT; von dem Borne PA; Boelens J; Steel E; Kampinga GA; Span LF; Lagrou K; Maertens JA; Dingemans GJ; Gaajetaan GR; van Tegelen DW; Cornelissen JJ; Vonk AG; Rijnders BJ
    J Antimicrob Chemother; 2016 Dec; 71(12):3528-3535. PubMed ID: 27530755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fatal invasive pulmonary and cerebral aspergillosis due to triazole-resistant Aspergillus fumigatus with multiple CYP51A mutations.
    Atamna A; Yeshurun M; Shargian L; Raanani P; Kramer M; Ben Zvi H; Ben Ami R; Marr KA; Bishara J
    J Antimicrob Chemother; 2024 May; 79(5):1191-1192. PubMed ID: 38334380
    [No Abstract]   [Full Text] [Related]  

  • 25. Azole-resistant Aspergillus fumigatus isolate with the TR34/L98H mutation in both a fungicide-sprayed field and the lung of a hematopoietic stem cell transplant recipient with invasive aspergillosis.
    Rocchi S; Daguindau E; Grenouillet F; Deconinck E; Bellanger AP; Garcia-Hermoso D; Bretagne S; Reboux G; Millon L
    J Clin Microbiol; 2014 May; 52(5):1724-6. PubMed ID: 24554754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple cyp51A-based mechanisms identified in azole-resistant isolates of Aspergillus fumigatus from China.
    Liu M; Zeng R; Zhang L; Li D; Lv G; Shen Y; Zheng H; Zhang Q; Zhao J; Zheng N; Liu W
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4321-5. PubMed ID: 25896700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies.
    Alanio A; Sitterlé E; Liance M; Farrugia C; Foulet F; Botterel F; Hicheri Y; Cordonnier C; Costa JM; Bretagne S
    J Antimicrob Chemother; 2011 Feb; 66(2):371-4. PubMed ID: 21131690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First clinical isolation report of azole-resistant Aspergillus fumigatus with TR
    Toyotome T; Hagiwara D; Kida H; Ogi T; Watanabe A; Wada T; Komatsu R; Kamei K
    J Infect Chemother; 2017 Aug; 23(8):579-581. PubMed ID: 28109740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-Level Pan-Azole-Resistant Aspergillosis.
    van Ingen J; van der Lee HA; Rijs AJ; Snelders E; Melchers WJ; Verweij PE
    J Clin Microbiol; 2015 Jul; 53(7):2343-5. PubMed ID: 25903576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Azole resistance in allergic bronchopulmonary aspergillosis and Aspergillus bronchitis.
    Howard SJ; Pasqualotto AC; Denning DW
    Clin Microbiol Infect; 2010 Jun; 16(6):683-8. PubMed ID: 19673966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New therapeutic strategies for invasive aspergillosis in the era of azole resistance: how should the prevalence of azole resistance be defined?
    Alanio A; Denis B; Hamane S; Raffoux E; Peffault de la Tour R; Touratier S; Bergeron A; Bretagne S
    J Antimicrob Chemother; 2016 Aug; 71(8):2075-8. PubMed ID: 27494830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus.
    Verweij PE; Ananda-Rajah M; Andes D; Arendrup MC; Brüggemann RJ; Chowdhary A; Cornely OA; Denning DW; Groll AH; Izumikawa K; Kullberg BJ; Lagrou K; Maertens J; Meis JF; Newton P; Page I; Seyedmousavi S; Sheppard DC; Viscoli C; Warris A; Donnelly JP
    Drug Resist Updat; 2015; 21-22():30-40. PubMed ID: 26282594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multi-azole-resistant Aspergillus fumigatus in the environment in Tanzania.
    Chowdhary A; Sharma C; van den Boom M; Yntema JB; Hagen F; Verweij PE; Meis JF
    J Antimicrob Chemother; 2014 Nov; 69(11):2979-83. PubMed ID: 25006238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sinus aspergillosis due to an azole-resistant Aspergillus fumigatus strain carrying the TR34/L98H mutation in immunocompetent host.
    Jeanvoine A; Rocchi S; Reboux G; Grenouillet F; Benassarou M; Chirouze C; Millon L
    Infect Dis (Lond); 2016 Oct; 48(10):765-6. PubMed ID: 27315172
    [No Abstract]   [Full Text] [Related]  

  • 35. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles.
    van der Linden JW; Camps SM; Kampinga GA; Arends JP; Debets-Ossenkopp YJ; Haas PJ; Rijnders BJ; Kuijper EJ; van Tiel FH; Varga J; Karawajczyk A; Zoll J; Melchers WJ; Verweij PE
    Clin Infect Dis; 2013 Aug; 57(4):513-20. PubMed ID: 23667263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Azole-resistant central nervous system aspergillosis.
    van der Linden JW; Jansen RR; Bresters D; Visser CE; Geerlings SE; Kuijper EJ; Melchers WJ; Verweij PE
    Clin Infect Dis; 2009 Apr; 48(8):1111-3. PubMed ID: 19272019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Azole resistant Aspergillus fumigatus: an emerging problem.
    Lelièvre L; Groh M; Angebault C; Maherault AC; Didier E; Bougnoux ME
    Med Mal Infect; 2013 Apr; 43(4):139-45. PubMed ID: 23562488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Azole-resistant Aspergillus fumigatus due to TR46/Y121F/T289A mutation emerging in Belgium, July 2012.
    Vermeulen E; Maertens J; Schoemans H; Lagrou K
    Euro Surveill; 2012 Nov; 17(48):. PubMed ID: 23218390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted gene disruption of the 14-alpha sterol demethylase (cyp51A) in Aspergillus fumigatus and its role in azole drug susceptibility.
    Mellado E; Garcia-Effron G; Buitrago MJ; Alcazar-Fuoli L; Cuenca-Estrella M; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2536-8. PubMed ID: 15917566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR/L98H, in a French cohort of patients with cystic fibrosis.
    Morio F; Aubin GG; Danner-Boucher I; Haloun A; Sacchetto E; Garcia-Hermoso D; Bretagne S; Miegeville M; Le Pape P
    J Antimicrob Chemother; 2012 Aug; 67(8):1870-3. PubMed ID: 22581906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.